PROMETRIKA Announces the Availability of Pharmacovigilance Services
News Jun 05, 2015
PROMETRIKA, LLC has expanded its offerings with the addition of pharmacovigilance services for clinical trials. PROMETRIKA has selected ARISg™, a world leader in safety data collection and reporting, as our service platform.
Our drug safety and regulatory affairs professionals, and expert physicians, each with more than 23 years in the biopharmaceutical industry, provide clinical interpretation and monitoring of safety trends.
PROMETRIKA’s CEO and President, Dr. Miganush Stepanians noted, “In response to our Sponsors’ increasing needs for accurate and dependable safety monitoring and reporting, we now offer trial safety monitoring with the worldwide reporting capabilities crucial in today’s drug development environment.”
Pharmacovigilance services for all phases of clinical trials can be provided as a stand-alone service or in conjunction with clinical operations, monitoring, data management, biostatistics, and medical writing services offered by PROMETRIKA.
Worms Exhibit Fear and Respond to Anti-anxiety MedsNews
A team of investigators has uncovered new clues about the mechanisms of fear and anxiety through an unlikely creature: the tiny nematode worm.READ MORE
Huntsman Cancer Institute Joins National Clinical Trial Targeting AMLNews
Huntsman Cancer Institute (HCI) at the University of Utah (U of U) has been selected to participate in the Beat AML Master Trial, an innovative clinical trial sponsored by The Leukemia & Lymphoma Society (LLS). The clinical trial is testing several new targeted therapies for the treatment of patients with acute myeloid leukemia (AML). HCI is the only facility in the Mountain West offering this trial to AML patients.READ MORE